Your browser doesn't support javascript.
loading
Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database.
Ziyadeh, Najat J; Geldhof, Anja; Noël, Wim; Otero-Lobato, Marijo; Esslinger, Suzan; Chakravarty, Soumya D; Wang, Yiting; Seeger, John D.
Afiliação
  • Ziyadeh NJ; Optum Epidemiology, 1325 Boylston Street, 11th Floor, Boston, MA, 02215, USA. najat.ziyadeh@optum.com.
  • Geldhof A; Janssen Biologics B.V., Leiden, The Netherlands.
  • Noël W; Janssen Biologics B.V., Leiden, The Netherlands.
  • Otero-Lobato M; Janssen Biologics B.V., Leiden, The Netherlands.
  • Esslinger S; Janssen Cilag GmbH International, Zug, Switzerland.
  • Chakravarty SD; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Wang Y; Drexel University School of Medicine, Philadelphia, PA, USA.
  • Seeger JD; Janssen Research and Development, LLC, Newark, NJ, USA.
Clin Drug Investig ; 40(11): 1021-1040, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32779120

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Reumáticas / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Reumáticas / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article